Consolidated Statements of Income - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Net sales	$ 9,770	$ 10,969
Cost of sales	8,230	9,142
Research and development expenses	179	190
Selling, general and administrative expenses	334	448
Amortization of intangibles	100	116
Restructuring and asset related charges - net	96	156
Integration and separation costs	65	452
Equity in losses of nonconsolidated affiliates	(89)	(14)
Sundry income (expense) - net	(81)	69
Interest income	15	18
Interest expense and amortization of debt discount	215	241
Income from continuing operations before income taxes	396	297
Provision for income taxes on continuing operations	138	141
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent	258	156
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent	0	445
Net income	258	601
Net income attributable to noncontrolling interests	19	45
Net income available for The Dow Chemical Company common stockholder	239	556
Depreciation	515	543
Capital expenditures	395	442
The Dow Chemical Company [Domain]
Net sales	9,770	10,969
Cost of sales	8,230	9,142
Research and development expenses	179	190
Selling, general and administrative expenses	334	448
Amortization of intangibles	100	116
Restructuring and asset related charges - net	96	156
Integration and separation costs	65	452
Equity in losses of nonconsolidated affiliates	(89)	(14)
Sundry income (expense) - net	(82)	69
Interest income	16	18
Interest expense and amortization of debt discount	215	241
Income from continuing operations before income taxes	396	297
Provision for income taxes on continuing operations	138	141
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent	258	156
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent	0	445
Net income	258	601
Net income attributable to noncontrolling interests	19	45
Net income available for The Dow Chemical Company common stockholder	239	556
Depreciation	515	543
Capital expenditures	$ 395	$ 442